LipoScience seeks FDA clearance for cardiovascular testing device

02/1/2010 | American City Business Journals

LipoScience has filed an application with the FDA seeking clearance for Vantera, a device that would enable research laboratories to conduct on-site testing of blood samples for risks of heart diseases. CEO Rick Brajer said he is hopeful the company can secure FDA clearance later this year.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX